An in vivo gene delivery approach for the isolation of reasonable numbers of type 2 innate lymphoid cells
Authors:
- Michael FrechMFMichael Frech
- Lisa KnipferLKLisa Knipfer
- Stefan WirtzSWStefan Wirtz
- Mario M. ZaissMario M. Zaiss
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SPP1937)
This publication has 15 references indexed in Scilit:
- Innate Lymphoid Cells: 10 Years OnCell, 2018
- Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cellsNature Immunology, 2015
- IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactionsProceedings of the National Academy of Sciences, 2015
- Isolation and analysis of group 2 innate lymphoid cells in miceNature Protocols, 2015
- IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cellsNature Immunology, 2014
- IL-33 is more potent than IL-25 in provoking IL-13–producing nuocytes (type 2 innate lymphoid cells) and airway contractionJournal of Allergy and Clinical Immunology, 2013
- The Transcription Factor GATA-3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid CellsImmunity, 2012
- Systemically dispersed innate IL-13–expressing cells in type 2 immunityProceedings of the National Academy of Sciences, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cellsNature, 2009